Dexmedetomidine
30561
Approved small_molecule active
Quick answer
Dexmedetomidine for Schizophrenia Agitation is a Approved program (small_molecule) at BioXcel Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- BioXcel Therapeutics
- Indication
- Schizophrenia Agitation
- Phase
- Approved
- Modality
- small_molecule
- Status
- active